Sterigenics buys amid speculation PE backer is looking to offload

By Gareth Macdonald contact

- Last updated on GMT

Competition heating up in sterilisation services sector
Competition heating up in sterilisation services sector

Related tags: Private equity, Goldman sachs

Sterigenics International has bought Italian gamma-ray sterilisation firm Gammarad in a deal that comes amid rumors that private equity owner GTCR is looking to offload the Illinois-based contractor.

Sterigenics announced its takeover of Bologna’s Gammarad last weekend, explaining that the deal – financial terms of which were not disclosed – will boost gamma irradiation offering in the pharmaceutical, biomedical, cosmetics and food sectors.

The acquisition is the third Sterigenics has made this year behind its takeover of Florida-based Food Technology Service, which it bought in March, and Canada’s Nordion which was purchased in August.

Sterigenics has 15 gamma irradiation contract services facilities in North America but – before the Gammarad deal – only operated one in Europe, which is at a site in Fleurus in Belgium.

Sale speculation

At present, Sterigenics is owned by private-equity organisation GTCR, which bought the contract sterilisation services firm from Silverfleet Capital for $675m in 2011.

Last week, Reuters reported that it had been told by unnamed “people familiar with the matte​r” that GTCR has called in Goldman Sachs and Jefferies have been called in to help it sell Sterigenics for $1.8bn​.

The rumors follow just a few days after rival Steris acquired Synergy Health, a health focused UK-based provider of contract sterilisation services.

At the time​, US rating agency Moody’s suggested that Sterigenics “will face increasing competitive pressure over the medium to long term​” as a result of the Steris acquisition.

Sterigenics did not make any mention of the sale rumors when announcing the Gammarad deal.

Instead CEO Michael Mulhern said: “Sterigenics has committed more than $32m in growth capital to expand existing facilities across the Americas and Europe​.”

Related news

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Local lab Data Management

Local lab Data Management

Q2 Solutions | 01-May-2020 | Data Sheet

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Q2 Solutions: Corporate Brochure

Q2 Solutions: Corporate Brochure

Q2 Solutions | 17-Apr-2020 | Product Brochure

We are an innovative, progressive and responsive partner with the global experience, medical expertise and focus on quality that is integral to drug, medical...

Related suppliers

Follow us


View more